SAN FRANCISCO - Biotechnology's famed "H&Q" meeting every January is known less as a hotbed of ideas than the place where financiers come together with biotechnology leaders for dealmaking - but one panel discussion challenged at least some attendees in the packed room to reconsider their ideas. (BioWorld Financial Watch) Read More
